Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer - Related Studies

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

This study is ongoing, but not recruiting participants.

Study NCT00019604. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Liver Cancer
		Metastatic Cancer

2	Additional conditions recognized in this trial
		Liver Neoplasms
		Neoplasm Metastasis

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Liver Diseases
		Neoplasms
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes

4	Interventions listed in this trial
		fludeoxyglucose F 18
		gadopentetate dimeglumine
		computed tomography
		magnetic resonance imaging
		positron emission tomography
		radiofrequency ablation
		radionuclide imaging
		ultrasound imaging

5	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)